Only 99 highly innovative companies across Europe are supported by the European Commission with a total of 627 million Euros to bring promising technologies to market.
The pilot phase of its clinical Performance Evaluation Study was completed with 100% accuracy and at least 7 hours shorter time-to-result (TTR) compared to gold standard methods.